Effects of homocysteine on acetylcholine‐ and adenosine‐induced vasodilatation of pancreatic vascular bed in rats
Authors:
- 1 September 1997
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (2) , 351-357
Abstract
Epidemiological and experimental data have shown that homocysteine may provoke vascular lesions and that moderate homocysteinaemia may constitute an independent risk factor for vascular disease. It is now documented that homocysteine damages human endothelial cells in culture, possibly by producing hydrogen peroxide in an oxygen‐dependent reaction. In this study, we have examined the direct effect of this sulphur amino acid on pancreatic vascular resistance. Experiments were performed on the vascular bed of the rat isolated pancreas perfused at constant pressure; thus, any change in pancreatic vascular resistance resulted in a change in the flow rate. D,L‐Homocysteine perfused for one hour at three different concentrations (200 μM, 2 mM, 20 mM) did not induce any significant change in the flow rate per se. Homocysteine infusion for 30 min at a concentration of 200 μM or 2 mM abolished the endothelium‐dependent vasodilatation induced by acetylcholine (0.05 μM), but did not modify adenosine (1.5 μM)‐induced vasodilatation. The effect of D,L‐homocysteine (200 μM or 2 mM) cannot be ascribed to a direct antimuscarinic effect since 30 min pretreatment of rat ileum with these concentrations did not significantly change the contractile effect of increasing concentrations of acetylcholine (0.015–15 μM). Preincubation of human umbilical vein endothelial cells with D,L‐homocysteine (0.2–5.0 mM) had no significant effect on overall cell number or viability during 18 h of incubation; the endothelial cells exposed to concentrations up to 5 mM exhibited a spindle‐shaped, whirled pattern. This pattern was reversed 48 h after the removal of homocysteine. A cytotoxic effect was seen after 18 h incubation in 10 mM D,L‐homocysteine. In conclusion, an acute infusion of homocysteine altered acetylcholine endothelium‐induced vasodilatation, whereas the adenosine vasodilatator effect was insensitive to the deleterious action of homocysteine in vitro. British Journal of Pharmacology (1997) 122, 351–357; doi:10.1038/sj.bjp.0701358Keywords
This publication has 52 references indexed in Scilit:
- Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folateThe American Journal of Cardiology, 1995
- Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parentsJACC, 1993
- Varying Extracellular [K+]Journal of Cardiovascular Pharmacology, 1993
- NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists.Circulation Research, 1993
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Endothelium‐dependent and BRL 34915‐induced vasodilatation in rat isolated perfused mesenteric arteries: role of G‐proteins, K+ and calcium channelsBritish Journal of Pharmacology, 1990
- Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.Stroke, 1990
- An A2‐purinoceptor agonist, NECA, potentiates acetylcholine‐induced glucagon secretionBritish Journal of Pharmacology, 1989
- Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vesselsBritish Journal of Pharmacology, 1988
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985